European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food.
You Might Also Like
A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
Optimizing Dietary Fiber Intake: Strategies for Human Nutrition and Food Science

